SlideShare a Scribd company logo
1 of 9
Download to read offline
GRAM STAIN
                             Preanalytical Considerations

I. PRINCIPLE
The Gram stain is used to classify bacteria on the basis of their forms, sizes,
cellular morphologies, and Gram reactions; in a clinical microbiology laboratory, it
is additionally a critical test for the rapid presumptive diagnosis of infectious
agents and serves to assess the quality of clinical specimens. The test was
originally developed by Christian Gram in 1884, but was modified by Hucker in
1921. The modified procedure provided greater reagent stability and better
differentiation of organisms. Other modifications have been specifically
developed for staining anaerobes and for weakly staining gram-negative bacilli
(Legionella spp., Campylobacter spp., Bacteroides spp. Fusobacterium spp.,
Brucella spp.) by using a carbol-fuchsin or basic fuchsin counterstain.
Interpretation of Gram-stained smears involves consideration of staining
characteristics and cell size, shape, and arrangement. These characteristics
may be influences by a number of variables, including culture age, media,
incubation atmosphere, staining methods, and the presence of inhibitory
substances. Similar considerations apply to the interpretation of smears from
clinical specimens, and additional factors include different host cell types and
possible phagocytosis.

Gram stain permits the separation of all bacteria into two large groups, those
which retain the primary dye (gram-positive) and those that take the color of the
counterstain (gram-negative). The primary dye is crystal violet and the secondary
dye is usually either safranin O or basic fuchsin. Some of the more common
formulations include: saturated crystal violet (approximately 1%), Hucker’s
crystal violet, and 2% alcoholic crystal violet.

II. SPECIMENS
Smears for Gram stain may be prepared from clinical specimens, broth cultures,
or colonies growing on solid media. Young cultures (<24 h) from noninhibitory
media and fresh clinical specimens yield the most accurate results, and for some
morphological parameters, broth culture smears are recommended.

III. MATERIALS
     A. Reagents: Reagents may be purchased commercially or prepared in
        the laboratory. The various Gram stain modifications and used are
        seen in Table 1.
           a.   Hucker’s modification
                     i. Crystal violet
                    ii. Gram’s iodine: Caution: Iodine is corrosive. Avoid inhalation, ingestion,
                        or skin contact.
                   iii. Decolorizers
                            1. Slowest: ethanol, 95%




1 Gram Stain Protocol
2.   Intermediate: acetone-alcohol; mixture of ethanol, 95% (100 ml)
                                 and acetone (reagent grade, 100 ml) Combine in a brown-glass
                                 bottle, label with 1-year expiration date, and store at room temp.
                            3.   Fastest: acetone (reagent grade) Caution: Ethanol and acetone
                                 are flammable.

   B. Supplies
           a.   Glass slides (25 by 75 mm), frosted ends desirable
           b.   0.85% NaCl, sterile
           c.   Pasteur pipettes and wood applicator sticks, sterile
           d.   Microbiological loops, inoculating needles
           e.   Supplies for disposal of biological waste, including “sharps”
           f.   Microincinerator or Bunsen burner
           g.   Immersion oil

   C. Equipment: Optional materials, depending on specimen source of
      laboratory protocol
           a.   Electric slide warmer, 60°C
           b.   Centrifuge
           c.   Cytospin centrifuge
           d.   Vortex mixer
           e.   Sterile tubes, screw cap
           f.   Sterile scissors, scalpels, forceps
           g.   Tissue grinder
           h.   Methanol, absolute: store methanol in brown screw-cap bottles. A working
                supply may be stored in plastic containers if replenished every 2 weeks.
           i.

                                 Analytical Considerations

IV. QUALITY CONTROL
    A.  Check appearance of reagents daily
           a.   If crystal violet has precipitate or crystal sediment, refilter before use even when
                purchased commercially. NOTE: Some stains, especially basic fuchsin and
                safranin, can become contaminated. When suspected, either culture or start with
                fresh material in a clean bottle.
           b.   Evaporation may alter reagent effectiveness; working solutions should be
                changed regularly if not depleted with normal use.

   B.      Daily and when a new lot is used, prepare a smear of Escherichia
           coli (ATCC 25922) and Staphylococcus epidermidis (ATCC 12228)
           or Staphylococcus aureus (ATCC 25923). Fix and stain as
           described. Expected results
           a.   Gram-negative bacilli, pink
           b.   Gram-positive cocci, deep violet NOTE: An alternative QC source is material
                scraped from between teeth with a wooden applicator stick; both gram-positive
                and –negative organisms will be present.
   C.      The following are some common causes of poor Gram stain
           results
           a.   Use of glass slides that have not been precleaned or degreased NOTE: Storing
                slides in a jar with 95% ethanol will ensure clean slides. Drain excess alcohol or
                flame slide before use.



2 Gram Stain Protocol
b.   Smear preparations that are too thick
           c.   Overheating of smears when heat fixation is used
           d.   Excessive rinsing during the staining procedure
   D.      To ensure accuracy of interpretation, set up a system for
           reviewing Gram stain reports.
           a.   Daily review of selected Gram stains by supervisory personnel may help
                determine competency/retraining needs and will help in correlating relevant
                clinical information.
           b.   Compare final culture results with Gram stain reports. NOTE: Not all organisms
                seen on a smear can be cultured.
           c.   A set of reference slides should be available for training and comparison.



V. PROCEDURE
   A.  Smear preparation: Proper smear preparation should produce a
       monolayer of organisms sufficiently dense for easy visualization
       but thin enough to reveal characteristic morphological
       characteristics. Use clean, new glass slides. NOTE: When using
       the same pipette or swab, always inoculate culture media first
       before preparing the smear.
       a. Clinical specimens: NOTE: Wear latex gloves and other protection
          required for universal precautions when handling clinical
          specimens. Observe other BSL 2 recommendations.
               i. Specimens received on swabs (A separate swab should
                  preferably be submitted).
                     1. Roll the swab gently across the slide to avoid
                         destruction of cellular elements and disruption of
                         bacterial arrangements.
                     2. Alternatively, when only one swab is received, place
                         the swab in a small amount of saline and vortex.
                         Squeeze the swab against the side of the tube, and
                         use the swab to prepare a smear. Use the remaining
                         suspension to inoculate culture media.
              ii. Specimens not received on swabs: aspirates, exudates,
                  sputa, stools
                     1. If the specimen is received in a syringe, first transfer
                         entire amount to a sterile tube; vortex specimen if
                         appropriate. NOTE: Do not accept syringes with
                         attached needles. Establish this policy and educate
                         all medical personnel regarding the need to remove
                         all needles before transport; observe universal
                         precautions.
                     2. Select purulent or blood-tinged portions by using a
                         sterile applicator stick, pipette, or wire loop. Very
                         thick or purulent specimens may be diluted in a drop
                         of saline on the slide for easier smear preparation.
                     3. Spread the sample over a large area of the slide to
                         form a thin film.


3 Gram Stain Protocol
iii. CSF and other body fluids requiring centrifugation: Some
                      laboratories may choose to use a Cytospin slide centrifuge
                      to concentrate body fluids for smear preparation. This
                      method has been recommended to increase Gram stain
                      sensitivity and to decrease centrifugation and examination
                      time for more rapid results. NOTE: Using slides with etched
                      rings helps to locate the inoculated area.
                          1. After centrifugation, use a sterile pipette to remove
                             supernatant to a sterile tube, leaving approximately
                             0.5 ml as sediment.
                          2. Vortex or forcefully aspirate the sediment in and out of
                             a sterile Pasteur pipette several times.
                          3. Use the Pasteur pipette to transfer a small drop of the
                             sediment to a clean slide.
                          4. Do not spread the drop out; allow it to air dry.
                iv. Urine specimen
                          1. Do not centrifuge; mix specimen well.
                          2. Use a sterile Pasteur pipette to transfer 1 drop to a
                             slide; do not spread the drop.
                          3. Allow the drop to dry
                  v. Dried material or very small amounts of clinical specimens
                          1. Emulsify specimen in 0.5 ml of sterile saline; vortex if
                             necessary.
                          2. Use a sterile Pasteur pipette to transfer 1 drop to a
                             slide
                          3. Use the pipette tip to spread the drop into an even
                             thin film
                vi. Biopsies and tissue sections: A “touch prep” and/or ground
                      specimen preparation
                          1. Mince with sterile scissors or scalpel
                          2. Prepare a “touch prep” - use sterile forceps to hold
                             pieces, and touch the sides of one or more of the
                             minced fragments to a sterile glass slide, grouping the
                             touches together for easier examination.
                          3. For homogenized ground specimens, place 1 drop
                             onto the slide and spread the material within a 1 inch
                             circle.
           b. Broth cultures: One smear per slide is recommended to avoid
              wash-off from one area to another during staining.
                   i. Use a sterile Pasteur pipette (or a venting needle for
                      containers with septa, such as blood culture bottles, to avoid
                      manipulating a needle and syringe) to transfer 1 or 2 drops
                      to the slide
                  ii. Spread drop into an even thin film
           c. Colonies from solid media



4 Gram Stain Protocol
i. Place a drop of sterile saline or water on the slide
                  ii. Transfer a small portion of colony with a sterile applicator
                      stick, wire needle, or loop.
                 iii. Gently mix to emulsify. NOTE: Never mix too vigorously;
                      avoid creation of aerosols.
   B.      Smear fixation: Smears may be fixed with heat or methanol
           a. Heat
                   i. Air dry smears on a flat surface, or place them on a 60°C
                      electric slide warmer until dry.
                  ii. If smears are air dried, pass them two or three times through
                      a flame, or hold the slide against the front of a
                      microincinerator for 5 to 10 s. To avoid distortions, do not
                      overheat.
                 iii. Allow slide to cool before staining.
           b. Methanol fixation prevents the lysis of RBCs, avoids damage to all
              host cells, and results in a cleaner background. It is strongly
              recommended for all clinical material, especially urines, and it also
              prevents wash-off of urine specimens.
                   i. Air dry the smear on a flat surface.
                  ii. Place a few drops of methanol on a slide for 1 min, drain off
                      remaining methanol without rinsing, and allow slide to air
                      dry.
                 iii. Do not use heat before staining.

   C.      Staining procedures
           a. Hucker’s modification
                   i. Flood the fixed smear with the crystal violet solution; allow
                      the stain to remain for 30 s.
                  ii. Decant crystal violet, and rinse slide gently with running
                      water. Caution: Excessive rinsing in this step could cause
                      crystal violet to be washed from gram-positive cells. The
                      flow of water may be applied to the underside of the angled
                      slide to ensure a gentle flow across the smeared side.
                 iii. Rinse off excess water with iodine solution, and then flood
                      the slide with fresh iodine solution. Allow the iodine to
                      remain for 3- s.
                 iv. Rinse gently with flowing tap water.
                  v. Decolorize by letting the reagent flow over the smear while
                      the slide is held at an angle. Stop when the runoff becomes
                      clear. Adjust decolorization time to thickness of the smear
                      and type of decolorizer used.
                 vi. Remove excess decolorizer with gentle flow of tap water.
                      NOTE: A properly decolorized smear appears with an
                      almost olive-green hue and without observable evidence of
                      crystal/gentian violet.




5 Gram Stain Protocol
vii. Flood the slide with safranin and allow counterstain to
                       remain for 30 s.
                 viii. Remove excess counterstain with a gentle flow of tap water.
                   ix. Drain slide, and air dry in an upright position. Clean off the
                       bottom of the slide by wiping the alcohol or aceto ne on a
                       tissue or paper towel.
                    x. Examine the smear microscopically.
            b. Basic/carbol-fuchsin counterstain (see Table 1 for timing).
               Basic/carbol-fuchsin is recommended for detecting faintly staining
               gram-negative organisms.
            c. Kopeloff’s modification is recommended for better visualization and
               differentiation of anaerobes, which may easily overdecolorize and
               stain faintly with Hucker’s modification (see Table 1).


                           Postanalytical Considerations


VI.      REPORTING RESULTS
      A.   Results and interpretation
           a. Evaluate the general nature of the smear under low-power
              magnification (10X).
                    i. Determine if smear has been properly decolorized.
                       Depending on the source of the specimen, the background
                       should be generally clear or gram negative. If WBCs are
                       present, they should appear completely gram negative. Do
                       not mistake thin crystal/gentian violet precipitate needles for
                       gram-positive bacillus-shaped bacteria.
                   ii. Determine if thickness of smear is appropriate. For proper
                       interpretation, areas must be no more than one cell thick
                       with no overlapping of cells.
           b. Examine smears prepared from clinical specimens under low power
              for evidence of inflammation. If appropriate for culture source, note
              the following:
                    i. Relative amounts of PMNs, mononuclear cells, and RBCs
                   ii. Relative amounts of squamous epithelial cells, bacteria
                       consistent with normal microbiota, which may indicate an
                       improperly collected specimen
                  iii. Location and arrangements of microorganisms
           c. Examine several areas of the smear under oil immersion for
              presence of microorganisms.
                    i. If no microorganisms are seen in a smear of a clinical
                       specimen, report “No microorganisms seen.”
                   ii. If microorganisms are seen, report relative numbers and
                       describe morphology.
           d. Observe predominant shapes of microorganisms



6 Gram Stain Protocol
i. Overall shape: coccus, coccoid, coccobacillary, bacilli,
                      filament, yeastlike
                  ii. Appearance of ends; rounded, tapered, flattened, clubbed
                      (swollen), concave, swelling of sides can suggest the
                      presence of spores but can also be caused by vacuoles,
                      marked pleomorphism, or irregular staining.
                 iii. Appearance of sides: parallel, ovoid (bulging), concave,
                      irregular
                 iv. Nature of axis: straight, curved, spiral
                  v. Pleomorphism (variation in shape): the descriptive term
                      “diptheroid” or “coryneform” is used to describe gram-
                      positive bacilli that are pleomorphic, club shaped, or
                      irregularly staining or that have palisading and/or angular
                      arrangements (V and L shapes).
                 vi. Branching or cellular extensions
   B.      Recording observations: Each laboratory must standardize
           specific reporting policies. Clinically significant findings should
           be called to the attention of the attending physician.
           a. Smears of clinical specimens: for urine cultures, examine 20 or
              more fields. Report as positive if an average of one or more
              organisms are seen per oil immersion field. This correlates with a
              colony count of =105 CFU/ml.
                   i. Record relative amounts of observed cells and
                      microorganisms. Commonly used quantitation systems
                      include the following.
                          1. Numerical
                                 a. 1+ (< 1 per oil immersion field, 100x)
                                 b. 2+ (1 per oil immersion field)
                                 c. 3+ (2 to 10 per oil immersion field)
                                 d. 4+ (predominant or >10 per oil immersion field)
                          2. Descriptive
                                 a. Rare (<1 per oil immersion field)
                                 b. Few (1 to 5 per oil immersion field)
                                 c. Moderate (5 to 10 per oil immersion field)
                                 d. Many (>10 per oil immersion field)
                  ii. Record the morphology of observed bacteria

   C.      Gram stain review
           a. After interpretation of smears, hold slides long enough to allow a
              confirmatory review, especially if culture or other lab test results are
              inconsistent.
                  i. Drain or gently blot excess oil
                 ii. For slide libraries and teaching collections that will be stored
                      for longer periods, immersion oil can be removed with xylene
                      solution and the slides can be coverslipped using Permount
                      to prevent fading.



7 Gram Stain Protocol
iii. When discarding stained smears, handle as biological waste
                        and use biohazard containers as required by local/state
                        regulations. Slides may puncture biohazard bags and
                        should be treated as “sharps.” Cardboard boxes or other
                        protective containers may be used.
            b. If a repeat Gram stain or a special stain to confirm findings
               suggested by a Gram smear interpretation is required when extra
               unstained smears are not available, a Gram-stained smear may be
               destained.
                     i. Remove immersion oil on the slide with xylene solution.
                    ii. Flood slide with acetone-alcohol until smear appears
                        colorless.
                   iii. Restain.

VII. LIMITATIONS OF THE PROCEDURE
    A.    Use results of Gram stains in conjunction with other clinical and
          laboratory findings. Use additional procedures (e.g., special stains,
          direct antigen tests, inclusion of selective media, etc.) to confirm
          findings suggested by Gram-stained smears.
    B.    Careful adherence to procedure and interpretative criteria is required
          for accurate results. Accuracy is highly dependent on the training and
          skill of microscopists.
    C.    Additional staining procedures are recommended for purulent clinical
          specimens in which no organisms are observed by the Gram stain
          method.
    D.    Gram stain-positive, culture-negative specimens may be the result of
          contamination of reagents and other supplies, presence of
          antimicrobial agents, or failure of organisms to grow under usual
          culture conditions (media, atmosphere, etc.)
    E.    False Gram stain results may be related to inadequately collected
          specimens.

SUPPLEMENTAL READING

Gram, C. 1884. Fosrtschr. Med. 2:185.

Isenberg, H.D. (ed). 1992. Clinical Microbiology Procedures Handbook . American Society for
Microbiology, Washington, D.C.

Isenberg, H.D. (ed). 1995. Essential Procedures for clinical Microbiology. American Society for
Microbiology, Washington, D.C.




8 Gram Stain Protocol
APPENDIX
Gram stain reagents available from Medical Chemical Corporation are as follows:

              REAGENT                      CATALOG           SIZE AND CATALOG
                                           NUMBER                 NUMBER
Acetone alcohol, 25% v/v                   304A         304A    8 oz (decolorizer)
                                                        304A    1 gal (decolorizer)
Acetone alcohol, 50% v/v                   305A
Crystal violet, 2% alcoholic               321, 583A
Crystal violet, Hucker’s                   514A
Crystal violet, saturated (approximately   512A         512A    8 oz
1%)                                                     512A    1 gal
Gram’s iodine                              322, 604A    604A    8 oz
                                                        604A    1 gal
Gram’s iodine, stabilized                  605A         605A    8 oz
        Has a longer shelf life, but is                 605A    1 gal
more difficult to use.
Reagent alcohol                            323, 374A
Safranin O, 0.4% w/v                       7965A        7965A 8 oz
                                                        7965A 1 gal
Safranin O, 1% w/v                         324, 7972A
Basic Fuchsin, 0.13% w/v                   435A         For better anaerobe staining
                                                        substitute basic fuchsin for safranin.

Gram’s stain kit, 2 oz                     320
       Contains the following:
         Crystal violet, 2% alcoholic
         Gram’s Iodine
         Reagent alcohol decolorizer
         Safranin O counterstain, 1%
w/v

Gram’s stain kit, 8 oz                     607K
       Contains the following:
         Crystal violet, saturated
         Gram’s Iodine
         Acetone-alcohol decolorizer
         Safranin O counterstain, 0.4%
w/v




9 Gram Stain Protocol

More Related Content

What's hot

Smear preparation techniques
Smear preparation techniquesSmear preparation techniques
Smear preparation techniques
Govardhan Joshi
 
SEMEN ANALYSIS POWERPOINT
SEMEN ANALYSIS POWERPOINTSEMEN ANALYSIS POWERPOINT
SEMEN ANALYSIS POWERPOINT
Wafa AlAhmed
 
Cervical cytopathology
Cervical cytopathologyCervical cytopathology
Cervical cytopathology
Monika Nema
 
Ppt flagella seminar
Ppt flagella seminarPpt flagella seminar
Ppt flagella seminar
Archa Dave
 
Posterior polar cataract
Posterior polar cataractPosterior polar cataract
Posterior polar cataract
Sumeet Agrawal
 
Bacteriology
BacteriologyBacteriology
Bacteriology
Naila Ansari
 

What's hot (20)

Eyes and Ears Medical Terminology
Eyes and Ears Medical TerminologyEyes and Ears Medical Terminology
Eyes and Ears Medical Terminology
 
Smear preparation techniques
Smear preparation techniquesSmear preparation techniques
Smear preparation techniques
 
STAINING TECHINIQUES
STAINING TECHINIQUESSTAINING TECHINIQUES
STAINING TECHINIQUES
 
SEMEN ANALYSIS POWERPOINT
SEMEN ANALYSIS POWERPOINTSEMEN ANALYSIS POWERPOINT
SEMEN ANALYSIS POWERPOINT
 
Romanowsky stains
Romanowsky stainsRomanowsky stains
Romanowsky stains
 
Staining ( rouine and special in cytology) rajiv kumar
Staining ( rouine and special in cytology) rajiv kumarStaining ( rouine and special in cytology) rajiv kumar
Staining ( rouine and special in cytology) rajiv kumar
 
cytopreparation techniques part 1
cytopreparation techniques part 1cytopreparation techniques part 1
cytopreparation techniques part 1
 
MCQ of ophthalmology(eyelids)
MCQ of ophthalmology(eyelids)MCQ of ophthalmology(eyelids)
MCQ of ophthalmology(eyelids)
 
Cervical cytopathology
Cervical cytopathologyCervical cytopathology
Cervical cytopathology
 
Ppt flagella seminar
Ppt flagella seminarPpt flagella seminar
Ppt flagella seminar
 
Color blindness
Color blindnessColor blindness
Color blindness
 
How to perform a two fold dilution in a clinical laboratory
How to perform a two fold dilution in a clinical laboratoryHow to perform a two fold dilution in a clinical laboratory
How to perform a two fold dilution in a clinical laboratory
 
Posterior polar cataract
Posterior polar cataractPosterior polar cataract
Posterior polar cataract
 
Sturm's Conoid
Sturm's ConoidSturm's Conoid
Sturm's Conoid
 
Fundus examination
Fundus   examinationFundus   examination
Fundus examination
 
Afb stain by manoj
Afb stain by manojAfb stain by manoj
Afb stain by manoj
 
Prepration and staining of blood film
Prepration and staining of blood filmPrepration and staining of blood film
Prepration and staining of blood film
 
Bacteriology
BacteriologyBacteriology
Bacteriology
 
Stool wet mount preparation
Stool wet mount preparationStool wet mount preparation
Stool wet mount preparation
 
Fluorescein Stain
Fluorescein Stain Fluorescein Stain
Fluorescein Stain
 

Similar to gramstain

Practical lab 2-dr saleh
Practical lab 2-dr salehPractical lab 2-dr saleh
Practical lab 2-dr saleh
MBBS IMS MSU
 
Chapter XIV Quality assurance in Bacteriology.ppt
Chapter XIV Quality assurance in Bacteriology.pptChapter XIV Quality assurance in Bacteriology.ppt
Chapter XIV Quality assurance in Bacteriology.ppt
StephenNjoroge22
 
STOOL_EXAMINATION.pptx
STOOL_EXAMINATION.pptxSTOOL_EXAMINATION.pptx
STOOL_EXAMINATION.pptx
KnqAutlawzvFb
 
diagnosticmethods-200213123837.pdf
diagnosticmethods-200213123837.pdfdiagnosticmethods-200213123837.pdf
diagnosticmethods-200213123837.pdf
Monish Pokra
 
Which Acne Medication Works Best
Which Acne Medication Works BestWhich Acne Medication Works Best
Which Acne Medication Works Best
Brett Larabie
 
1-introductionbacteria
1-introductionbacteria1-introductionbacteria
1-introductionbacteria
Siti Mastura
 
Phages presentation final final final
Phages presentation  final final finalPhages presentation  final final final
Phages presentation final final final
nicollearosa
 
Phages presentation final final final
Phages presentation  final final finalPhages presentation  final final final
Phages presentation final final final
anaelishockey
 

Similar to gramstain (20)

Staning 1&2.pptx
Staning 1&2.pptxStaning 1&2.pptx
Staning 1&2.pptx
 
Practical lab 2-dr saleh
Practical lab 2-dr salehPractical lab 2-dr saleh
Practical lab 2-dr saleh
 
Chapter XIV Quality assurance in Bacteriology.ppt
Chapter XIV Quality assurance in Bacteriology.pptChapter XIV Quality assurance in Bacteriology.ppt
Chapter XIV Quality assurance in Bacteriology.ppt
 
2006 practical pharmacognosy manual notes
2006   practical pharmacognosy manual notes2006   practical pharmacognosy manual notes
2006 practical pharmacognosy manual notes
 
STOOL_EXAMINATION.pptx
STOOL_EXAMINATION.pptxSTOOL_EXAMINATION.pptx
STOOL_EXAMINATION.pptx
 
ATCC y otros reguladores internacionales de bioderivados.
ATCC y otros reguladores internacionales de bioderivados.ATCC y otros reguladores internacionales de bioderivados.
ATCC y otros reguladores internacionales de bioderivados.
 
Human orosomucoid-2-elisa-kit
Human orosomucoid-2-elisa-kitHuman orosomucoid-2-elisa-kit
Human orosomucoid-2-elisa-kit
 
diagnosticmethods-200213123837.pdf
diagnosticmethods-200213123837.pdfdiagnosticmethods-200213123837.pdf
diagnosticmethods-200213123837.pdf
 
Diagnostic methods of Parasites
Diagnostic methods of ParasitesDiagnostic methods of Parasites
Diagnostic methods of Parasites
 
Which Acne Medication Works Best
Which Acne Medication Works BestWhich Acne Medication Works Best
Which Acne Medication Works Best
 
1-introductionbacteria
1-introductionbacteria1-introductionbacteria
1-introductionbacteria
 
Dr.farouk practicals
Dr.farouk practicalsDr.farouk practicals
Dr.farouk practicals
 
Lab 4
Lab 4Lab 4
Lab 4
 
Phages presentation final final final
Phages presentation  final final finalPhages presentation  final final final
Phages presentation final final final
 
Qc test for plastics,metallic tins,closures, collapsible tubes, secondary pac...
Qc test for plastics,metallic tins,closures, collapsible tubes, secondary pac...Qc test for plastics,metallic tins,closures, collapsible tubes, secondary pac...
Qc test for plastics,metallic tins,closures, collapsible tubes, secondary pac...
 
Phages presentation final final final
Phages presentation  final final finalPhages presentation  final final final
Phages presentation final final final
 
INTRODUCTION TO MICRO LAB, STAINING TECHNIQUES & MORPHOLOGY OF BACTERIA
INTRODUCTION TO MICRO LAB, STAINING TECHNIQUES & MORPHOLOGY OF BACTERIAINTRODUCTION TO MICRO LAB, STAINING TECHNIQUES & MORPHOLOGY OF BACTERIA
INTRODUCTION TO MICRO LAB, STAINING TECHNIQUES & MORPHOLOGY OF BACTERIA
 
2015 mibi lab_manual
2015 mibi lab_manual2015 mibi lab_manual
2015 mibi lab_manual
 
Lab Report: Isolation of Pure Culture, Gram-staining, and Microscopic Observa...
Lab Report: Isolation of Pure Culture, Gram-staining, and Microscopic Observa...Lab Report: Isolation of Pure Culture, Gram-staining, and Microscopic Observa...
Lab Report: Isolation of Pure Culture, Gram-staining, and Microscopic Observa...
 
CHAPTER 6.pptx
CHAPTER 6.pptxCHAPTER 6.pptx
CHAPTER 6.pptx
 

More from Siti Mastura

Poster on Psychosocial risk factors and musculoskeletal symptoms among nurses
Poster on Psychosocial risk factors and musculoskeletal symptoms among nursesPoster on Psychosocial risk factors and musculoskeletal symptoms among nurses
Poster on Psychosocial risk factors and musculoskeletal symptoms among nurses
Siti Mastura
 
PenyakitKelamin
PenyakitKelaminPenyakitKelamin
PenyakitKelamin
Siti Mastura
 
valuation of toxicological implications of inhalationexposure to kerosene fum...
valuation of toxicological implications of inhalationexposure to kerosene fum...valuation of toxicological implications of inhalationexposure to kerosene fum...
valuation of toxicological implications of inhalationexposure to kerosene fum...
Siti Mastura
 
865_file_UNEP__20Emergency__20Preparedness_final
865_file_UNEP__20Emergency__20Preparedness_final865_file_UNEP__20Emergency__20Preparedness_final
865_file_UNEP__20Emergency__20Preparedness_final
Siti Mastura
 
Principles_Of_Hazard_Tree_Risk_Mgmnt
Principles_Of_Hazard_Tree_Risk_MgmntPrinciples_Of_Hazard_Tree_Risk_Mgmnt
Principles_Of_Hazard_Tree_Risk_Mgmnt
Siti Mastura
 
fire fighting prevention
fire fighting preventionfire fighting prevention
fire fighting prevention
Siti Mastura
 
PIHAK BERKUASA TEMPATAN
PIHAK BERKUASA TEMPATANPIHAK BERKUASA TEMPATAN
PIHAK BERKUASA TEMPATAN
Siti Mastura
 
stpfaulttree
stpfaulttreestpfaulttree
stpfaulttree
Siti Mastura
 
Guidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent Vapor
Guidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent VaporGuidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent Vapor
Guidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent Vapor
Siti Mastura
 
jurnal of occupational safety and health
jurnal of occupational safety and healthjurnal of occupational safety and health
jurnal of occupational safety and health
Siti Mastura
 
Requirement and Technical Standard for Non Convention Cargo
Requirement and Technical Standard for Non Convention Cargo Requirement and Technical Standard for Non Convention Cargo
Requirement and Technical Standard for Non Convention Cargo
Siti Mastura
 
fault tree analysis
fault tree analysisfault tree analysis
fault tree analysis
Siti Mastura
 
Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...
Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...
Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...
Siti Mastura
 
japanese encephalitis
japanese encephalitisjapanese encephalitis
japanese encephalitis
Siti Mastura
 
Communication for behavioral impact(COMBI)
Communication for behavioral impact(COMBI)Communication for behavioral impact(COMBI)
Communication for behavioral impact(COMBI)
Siti Mastura
 
VECTOR CONTROL
VECTOR CONTROLVECTOR CONTROL
VECTOR CONTROL
Siti Mastura
 
nominal group technique
nominal group techniquenominal group technique
nominal group technique
Siti Mastura
 
157-national-medicines-policy-of-malaysia
157-national-medicines-policy-of-malaysia157-national-medicines-policy-of-malaysia
157-national-medicines-policy-of-malaysia
Siti Mastura
 

More from Siti Mastura (20)

Poster on Psychosocial risk factors and musculoskeletal symptoms among nurses
Poster on Psychosocial risk factors and musculoskeletal symptoms among nursesPoster on Psychosocial risk factors and musculoskeletal symptoms among nurses
Poster on Psychosocial risk factors and musculoskeletal symptoms among nurses
 
PSYCHOSOCIAL RISK FACTORS AND MUSCULOSKELETAL SYMPTOMS AMONG NURSES
PSYCHOSOCIAL RISK FACTORS AND MUSCULOSKELETAL SYMPTOMS AMONG NURSESPSYCHOSOCIAL RISK FACTORS AND MUSCULOSKELETAL SYMPTOMS AMONG NURSES
PSYCHOSOCIAL RISK FACTORS AND MUSCULOSKELETAL SYMPTOMS AMONG NURSES
 
PenyakitKelamin
PenyakitKelaminPenyakitKelamin
PenyakitKelamin
 
valuation of toxicological implications of inhalationexposure to kerosene fum...
valuation of toxicological implications of inhalationexposure to kerosene fum...valuation of toxicological implications of inhalationexposure to kerosene fum...
valuation of toxicological implications of inhalationexposure to kerosene fum...
 
SPSS GUIDE
SPSS GUIDESPSS GUIDE
SPSS GUIDE
 
865_file_UNEP__20Emergency__20Preparedness_final
865_file_UNEP__20Emergency__20Preparedness_final865_file_UNEP__20Emergency__20Preparedness_final
865_file_UNEP__20Emergency__20Preparedness_final
 
Principles_Of_Hazard_Tree_Risk_Mgmnt
Principles_Of_Hazard_Tree_Risk_MgmntPrinciples_Of_Hazard_Tree_Risk_Mgmnt
Principles_Of_Hazard_Tree_Risk_Mgmnt
 
fire fighting prevention
fire fighting preventionfire fighting prevention
fire fighting prevention
 
PIHAK BERKUASA TEMPATAN
PIHAK BERKUASA TEMPATANPIHAK BERKUASA TEMPATAN
PIHAK BERKUASA TEMPATAN
 
stpfaulttree
stpfaulttreestpfaulttree
stpfaulttree
 
Guidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent Vapor
Guidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent VaporGuidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent Vapor
Guidelines for Incident Commanders- Final ReportFFPE Use in Chemical Agent Vapor
 
jurnal of occupational safety and health
jurnal of occupational safety and healthjurnal of occupational safety and health
jurnal of occupational safety and health
 
Requirement and Technical Standard for Non Convention Cargo
Requirement and Technical Standard for Non Convention Cargo Requirement and Technical Standard for Non Convention Cargo
Requirement and Technical Standard for Non Convention Cargo
 
fault tree analysis
fault tree analysisfault tree analysis
fault tree analysis
 
Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...
Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...
Communicable_Diseases_Guidelines_for_Prevention_and_Control_Japanese_Encephal...
 
japanese encephalitis
japanese encephalitisjapanese encephalitis
japanese encephalitis
 
Communication for behavioral impact(COMBI)
Communication for behavioral impact(COMBI)Communication for behavioral impact(COMBI)
Communication for behavioral impact(COMBI)
 
VECTOR CONTROL
VECTOR CONTROLVECTOR CONTROL
VECTOR CONTROL
 
nominal group technique
nominal group techniquenominal group technique
nominal group technique
 
157-national-medicines-policy-of-malaysia
157-national-medicines-policy-of-malaysia157-national-medicines-policy-of-malaysia
157-national-medicines-policy-of-malaysia
 

Recently uploaded

+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
?#DUbAI#??##{{(☎️+971_581248768%)**%*]'#abortion pills for sale in dubai@
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
WSO2
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Safe Software
 

Recently uploaded (20)

TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
 
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
+971581248768>> SAFE AND ORIGINAL ABORTION PILLS FOR SALE IN DUBAI AND ABUDHA...
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 AmsterdamDEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
DEV meet-up UiPath Document Understanding May 7 2024 Amsterdam
 
MS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectorsMS Copilot expands with MS Graph connectors
MS Copilot expands with MS Graph connectors
 
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
Apidays New York 2024 - Passkeys: Developing APIs to enable passwordless auth...
 
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
Exploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with MilvusExploring Multimodal Embeddings with Milvus
Exploring Multimodal Embeddings with Milvus
 
ICT role in 21st century education and its challenges
ICT role in 21st century education and its challengesICT role in 21st century education and its challenges
ICT role in 21st century education and its challenges
 
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot TakeoffStrategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
Strategize a Smooth Tenant-to-tenant Migration and Copilot Takeoff
 
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
Emergent Methods: Multi-lingual narrative tracking in the news - real-time ex...
 
Strategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a FresherStrategies for Landing an Oracle DBA Job as a Fresher
Strategies for Landing an Oracle DBA Job as a Fresher
 
presentation ICT roal in 21st century education
presentation ICT roal in 21st century educationpresentation ICT roal in 21st century education
presentation ICT roal in 21st century education
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUKSpring Boot vs Quarkus the ultimate battle - DevoxxUK
Spring Boot vs Quarkus the ultimate battle - DevoxxUK
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers:  A Deep Dive into Serverless Spatial Data and FMECloud Frontiers:  A Deep Dive into Serverless Spatial Data and FME
Cloud Frontiers: A Deep Dive into Serverless Spatial Data and FME
 

gramstain

  • 1. GRAM STAIN Preanalytical Considerations I. PRINCIPLE The Gram stain is used to classify bacteria on the basis of their forms, sizes, cellular morphologies, and Gram reactions; in a clinical microbiology laboratory, it is additionally a critical test for the rapid presumptive diagnosis of infectious agents and serves to assess the quality of clinical specimens. The test was originally developed by Christian Gram in 1884, but was modified by Hucker in 1921. The modified procedure provided greater reagent stability and better differentiation of organisms. Other modifications have been specifically developed for staining anaerobes and for weakly staining gram-negative bacilli (Legionella spp., Campylobacter spp., Bacteroides spp. Fusobacterium spp., Brucella spp.) by using a carbol-fuchsin or basic fuchsin counterstain. Interpretation of Gram-stained smears involves consideration of staining characteristics and cell size, shape, and arrangement. These characteristics may be influences by a number of variables, including culture age, media, incubation atmosphere, staining methods, and the presence of inhibitory substances. Similar considerations apply to the interpretation of smears from clinical specimens, and additional factors include different host cell types and possible phagocytosis. Gram stain permits the separation of all bacteria into two large groups, those which retain the primary dye (gram-positive) and those that take the color of the counterstain (gram-negative). The primary dye is crystal violet and the secondary dye is usually either safranin O or basic fuchsin. Some of the more common formulations include: saturated crystal violet (approximately 1%), Hucker’s crystal violet, and 2% alcoholic crystal violet. II. SPECIMENS Smears for Gram stain may be prepared from clinical specimens, broth cultures, or colonies growing on solid media. Young cultures (<24 h) from noninhibitory media and fresh clinical specimens yield the most accurate results, and for some morphological parameters, broth culture smears are recommended. III. MATERIALS A. Reagents: Reagents may be purchased commercially or prepared in the laboratory. The various Gram stain modifications and used are seen in Table 1. a. Hucker’s modification i. Crystal violet ii. Gram’s iodine: Caution: Iodine is corrosive. Avoid inhalation, ingestion, or skin contact. iii. Decolorizers 1. Slowest: ethanol, 95% 1 Gram Stain Protocol
  • 2. 2. Intermediate: acetone-alcohol; mixture of ethanol, 95% (100 ml) and acetone (reagent grade, 100 ml) Combine in a brown-glass bottle, label with 1-year expiration date, and store at room temp. 3. Fastest: acetone (reagent grade) Caution: Ethanol and acetone are flammable. B. Supplies a. Glass slides (25 by 75 mm), frosted ends desirable b. 0.85% NaCl, sterile c. Pasteur pipettes and wood applicator sticks, sterile d. Microbiological loops, inoculating needles e. Supplies for disposal of biological waste, including “sharps” f. Microincinerator or Bunsen burner g. Immersion oil C. Equipment: Optional materials, depending on specimen source of laboratory protocol a. Electric slide warmer, 60°C b. Centrifuge c. Cytospin centrifuge d. Vortex mixer e. Sterile tubes, screw cap f. Sterile scissors, scalpels, forceps g. Tissue grinder h. Methanol, absolute: store methanol in brown screw-cap bottles. A working supply may be stored in plastic containers if replenished every 2 weeks. i. Analytical Considerations IV. QUALITY CONTROL A. Check appearance of reagents daily a. If crystal violet has precipitate or crystal sediment, refilter before use even when purchased commercially. NOTE: Some stains, especially basic fuchsin and safranin, can become contaminated. When suspected, either culture or start with fresh material in a clean bottle. b. Evaporation may alter reagent effectiveness; working solutions should be changed regularly if not depleted with normal use. B. Daily and when a new lot is used, prepare a smear of Escherichia coli (ATCC 25922) and Staphylococcus epidermidis (ATCC 12228) or Staphylococcus aureus (ATCC 25923). Fix and stain as described. Expected results a. Gram-negative bacilli, pink b. Gram-positive cocci, deep violet NOTE: An alternative QC source is material scraped from between teeth with a wooden applicator stick; both gram-positive and –negative organisms will be present. C. The following are some common causes of poor Gram stain results a. Use of glass slides that have not been precleaned or degreased NOTE: Storing slides in a jar with 95% ethanol will ensure clean slides. Drain excess alcohol or flame slide before use. 2 Gram Stain Protocol
  • 3. b. Smear preparations that are too thick c. Overheating of smears when heat fixation is used d. Excessive rinsing during the staining procedure D. To ensure accuracy of interpretation, set up a system for reviewing Gram stain reports. a. Daily review of selected Gram stains by supervisory personnel may help determine competency/retraining needs and will help in correlating relevant clinical information. b. Compare final culture results with Gram stain reports. NOTE: Not all organisms seen on a smear can be cultured. c. A set of reference slides should be available for training and comparison. V. PROCEDURE A. Smear preparation: Proper smear preparation should produce a monolayer of organisms sufficiently dense for easy visualization but thin enough to reveal characteristic morphological characteristics. Use clean, new glass slides. NOTE: When using the same pipette or swab, always inoculate culture media first before preparing the smear. a. Clinical specimens: NOTE: Wear latex gloves and other protection required for universal precautions when handling clinical specimens. Observe other BSL 2 recommendations. i. Specimens received on swabs (A separate swab should preferably be submitted). 1. Roll the swab gently across the slide to avoid destruction of cellular elements and disruption of bacterial arrangements. 2. Alternatively, when only one swab is received, place the swab in a small amount of saline and vortex. Squeeze the swab against the side of the tube, and use the swab to prepare a smear. Use the remaining suspension to inoculate culture media. ii. Specimens not received on swabs: aspirates, exudates, sputa, stools 1. If the specimen is received in a syringe, first transfer entire amount to a sterile tube; vortex specimen if appropriate. NOTE: Do not accept syringes with attached needles. Establish this policy and educate all medical personnel regarding the need to remove all needles before transport; observe universal precautions. 2. Select purulent or blood-tinged portions by using a sterile applicator stick, pipette, or wire loop. Very thick or purulent specimens may be diluted in a drop of saline on the slide for easier smear preparation. 3. Spread the sample over a large area of the slide to form a thin film. 3 Gram Stain Protocol
  • 4. iii. CSF and other body fluids requiring centrifugation: Some laboratories may choose to use a Cytospin slide centrifuge to concentrate body fluids for smear preparation. This method has been recommended to increase Gram stain sensitivity and to decrease centrifugation and examination time for more rapid results. NOTE: Using slides with etched rings helps to locate the inoculated area. 1. After centrifugation, use a sterile pipette to remove supernatant to a sterile tube, leaving approximately 0.5 ml as sediment. 2. Vortex or forcefully aspirate the sediment in and out of a sterile Pasteur pipette several times. 3. Use the Pasteur pipette to transfer a small drop of the sediment to a clean slide. 4. Do not spread the drop out; allow it to air dry. iv. Urine specimen 1. Do not centrifuge; mix specimen well. 2. Use a sterile Pasteur pipette to transfer 1 drop to a slide; do not spread the drop. 3. Allow the drop to dry v. Dried material or very small amounts of clinical specimens 1. Emulsify specimen in 0.5 ml of sterile saline; vortex if necessary. 2. Use a sterile Pasteur pipette to transfer 1 drop to a slide 3. Use the pipette tip to spread the drop into an even thin film vi. Biopsies and tissue sections: A “touch prep” and/or ground specimen preparation 1. Mince with sterile scissors or scalpel 2. Prepare a “touch prep” - use sterile forceps to hold pieces, and touch the sides of one or more of the minced fragments to a sterile glass slide, grouping the touches together for easier examination. 3. For homogenized ground specimens, place 1 drop onto the slide and spread the material within a 1 inch circle. b. Broth cultures: One smear per slide is recommended to avoid wash-off from one area to another during staining. i. Use a sterile Pasteur pipette (or a venting needle for containers with septa, such as blood culture bottles, to avoid manipulating a needle and syringe) to transfer 1 or 2 drops to the slide ii. Spread drop into an even thin film c. Colonies from solid media 4 Gram Stain Protocol
  • 5. i. Place a drop of sterile saline or water on the slide ii. Transfer a small portion of colony with a sterile applicator stick, wire needle, or loop. iii. Gently mix to emulsify. NOTE: Never mix too vigorously; avoid creation of aerosols. B. Smear fixation: Smears may be fixed with heat or methanol a. Heat i. Air dry smears on a flat surface, or place them on a 60°C electric slide warmer until dry. ii. If smears are air dried, pass them two or three times through a flame, or hold the slide against the front of a microincinerator for 5 to 10 s. To avoid distortions, do not overheat. iii. Allow slide to cool before staining. b. Methanol fixation prevents the lysis of RBCs, avoids damage to all host cells, and results in a cleaner background. It is strongly recommended for all clinical material, especially urines, and it also prevents wash-off of urine specimens. i. Air dry the smear on a flat surface. ii. Place a few drops of methanol on a slide for 1 min, drain off remaining methanol without rinsing, and allow slide to air dry. iii. Do not use heat before staining. C. Staining procedures a. Hucker’s modification i. Flood the fixed smear with the crystal violet solution; allow the stain to remain for 30 s. ii. Decant crystal violet, and rinse slide gently with running water. Caution: Excessive rinsing in this step could cause crystal violet to be washed from gram-positive cells. The flow of water may be applied to the underside of the angled slide to ensure a gentle flow across the smeared side. iii. Rinse off excess water with iodine solution, and then flood the slide with fresh iodine solution. Allow the iodine to remain for 3- s. iv. Rinse gently with flowing tap water. v. Decolorize by letting the reagent flow over the smear while the slide is held at an angle. Stop when the runoff becomes clear. Adjust decolorization time to thickness of the smear and type of decolorizer used. vi. Remove excess decolorizer with gentle flow of tap water. NOTE: A properly decolorized smear appears with an almost olive-green hue and without observable evidence of crystal/gentian violet. 5 Gram Stain Protocol
  • 6. vii. Flood the slide with safranin and allow counterstain to remain for 30 s. viii. Remove excess counterstain with a gentle flow of tap water. ix. Drain slide, and air dry in an upright position. Clean off the bottom of the slide by wiping the alcohol or aceto ne on a tissue or paper towel. x. Examine the smear microscopically. b. Basic/carbol-fuchsin counterstain (see Table 1 for timing). Basic/carbol-fuchsin is recommended for detecting faintly staining gram-negative organisms. c. Kopeloff’s modification is recommended for better visualization and differentiation of anaerobes, which may easily overdecolorize and stain faintly with Hucker’s modification (see Table 1). Postanalytical Considerations VI. REPORTING RESULTS A. Results and interpretation a. Evaluate the general nature of the smear under low-power magnification (10X). i. Determine if smear has been properly decolorized. Depending on the source of the specimen, the background should be generally clear or gram negative. If WBCs are present, they should appear completely gram negative. Do not mistake thin crystal/gentian violet precipitate needles for gram-positive bacillus-shaped bacteria. ii. Determine if thickness of smear is appropriate. For proper interpretation, areas must be no more than one cell thick with no overlapping of cells. b. Examine smears prepared from clinical specimens under low power for evidence of inflammation. If appropriate for culture source, note the following: i. Relative amounts of PMNs, mononuclear cells, and RBCs ii. Relative amounts of squamous epithelial cells, bacteria consistent with normal microbiota, which may indicate an improperly collected specimen iii. Location and arrangements of microorganisms c. Examine several areas of the smear under oil immersion for presence of microorganisms. i. If no microorganisms are seen in a smear of a clinical specimen, report “No microorganisms seen.” ii. If microorganisms are seen, report relative numbers and describe morphology. d. Observe predominant shapes of microorganisms 6 Gram Stain Protocol
  • 7. i. Overall shape: coccus, coccoid, coccobacillary, bacilli, filament, yeastlike ii. Appearance of ends; rounded, tapered, flattened, clubbed (swollen), concave, swelling of sides can suggest the presence of spores but can also be caused by vacuoles, marked pleomorphism, or irregular staining. iii. Appearance of sides: parallel, ovoid (bulging), concave, irregular iv. Nature of axis: straight, curved, spiral v. Pleomorphism (variation in shape): the descriptive term “diptheroid” or “coryneform” is used to describe gram- positive bacilli that are pleomorphic, club shaped, or irregularly staining or that have palisading and/or angular arrangements (V and L shapes). vi. Branching or cellular extensions B. Recording observations: Each laboratory must standardize specific reporting policies. Clinically significant findings should be called to the attention of the attending physician. a. Smears of clinical specimens: for urine cultures, examine 20 or more fields. Report as positive if an average of one or more organisms are seen per oil immersion field. This correlates with a colony count of =105 CFU/ml. i. Record relative amounts of observed cells and microorganisms. Commonly used quantitation systems include the following. 1. Numerical a. 1+ (< 1 per oil immersion field, 100x) b. 2+ (1 per oil immersion field) c. 3+ (2 to 10 per oil immersion field) d. 4+ (predominant or >10 per oil immersion field) 2. Descriptive a. Rare (<1 per oil immersion field) b. Few (1 to 5 per oil immersion field) c. Moderate (5 to 10 per oil immersion field) d. Many (>10 per oil immersion field) ii. Record the morphology of observed bacteria C. Gram stain review a. After interpretation of smears, hold slides long enough to allow a confirmatory review, especially if culture or other lab test results are inconsistent. i. Drain or gently blot excess oil ii. For slide libraries and teaching collections that will be stored for longer periods, immersion oil can be removed with xylene solution and the slides can be coverslipped using Permount to prevent fading. 7 Gram Stain Protocol
  • 8. iii. When discarding stained smears, handle as biological waste and use biohazard containers as required by local/state regulations. Slides may puncture biohazard bags and should be treated as “sharps.” Cardboard boxes or other protective containers may be used. b. If a repeat Gram stain or a special stain to confirm findings suggested by a Gram smear interpretation is required when extra unstained smears are not available, a Gram-stained smear may be destained. i. Remove immersion oil on the slide with xylene solution. ii. Flood slide with acetone-alcohol until smear appears colorless. iii. Restain. VII. LIMITATIONS OF THE PROCEDURE A. Use results of Gram stains in conjunction with other clinical and laboratory findings. Use additional procedures (e.g., special stains, direct antigen tests, inclusion of selective media, etc.) to confirm findings suggested by Gram-stained smears. B. Careful adherence to procedure and interpretative criteria is required for accurate results. Accuracy is highly dependent on the training and skill of microscopists. C. Additional staining procedures are recommended for purulent clinical specimens in which no organisms are observed by the Gram stain method. D. Gram stain-positive, culture-negative specimens may be the result of contamination of reagents and other supplies, presence of antimicrobial agents, or failure of organisms to grow under usual culture conditions (media, atmosphere, etc.) E. False Gram stain results may be related to inadequately collected specimens. SUPPLEMENTAL READING Gram, C. 1884. Fosrtschr. Med. 2:185. Isenberg, H.D. (ed). 1992. Clinical Microbiology Procedures Handbook . American Society for Microbiology, Washington, D.C. Isenberg, H.D. (ed). 1995. Essential Procedures for clinical Microbiology. American Society for Microbiology, Washington, D.C. 8 Gram Stain Protocol
  • 9. APPENDIX Gram stain reagents available from Medical Chemical Corporation are as follows: REAGENT CATALOG SIZE AND CATALOG NUMBER NUMBER Acetone alcohol, 25% v/v 304A 304A 8 oz (decolorizer) 304A 1 gal (decolorizer) Acetone alcohol, 50% v/v 305A Crystal violet, 2% alcoholic 321, 583A Crystal violet, Hucker’s 514A Crystal violet, saturated (approximately 512A 512A 8 oz 1%) 512A 1 gal Gram’s iodine 322, 604A 604A 8 oz 604A 1 gal Gram’s iodine, stabilized 605A 605A 8 oz Has a longer shelf life, but is 605A 1 gal more difficult to use. Reagent alcohol 323, 374A Safranin O, 0.4% w/v 7965A 7965A 8 oz 7965A 1 gal Safranin O, 1% w/v 324, 7972A Basic Fuchsin, 0.13% w/v 435A For better anaerobe staining substitute basic fuchsin for safranin. Gram’s stain kit, 2 oz 320 Contains the following: Crystal violet, 2% alcoholic Gram’s Iodine Reagent alcohol decolorizer Safranin O counterstain, 1% w/v Gram’s stain kit, 8 oz 607K Contains the following: Crystal violet, saturated Gram’s Iodine Acetone-alcohol decolorizer Safranin O counterstain, 0.4% w/v 9 Gram Stain Protocol